We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
August 2019
IQ DILI collaborated with Biorepository, nationwide DILI experts in industry, academia, and US FDA to develop comprehensive guidelines addressing best practices for bio specimen collection.
April 2019
IQ Consortium Analytical Leadership Group's Dissolution Working Group Starts Public Webinar Series
February 2019
IQ has released a series of case studies on high-impact initiatives led by IQ working groups.
There are currently no events to display